Medicine
Captopril 12.5 mg tablet
Captopril 12.5 mg tablet is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Captopril
- Brand
- Sold under the generic name
- Strength
- 12.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 100 blister pack and 16 more
- Manufacturers
- Ajanta PharmaIndiaCamber PharmaceuticalsIndiaMethod PharmaceuticalsAmici PharmaHikma PharmaceuticalsSolco HealthcareAiPing PharmaceuticalAmerican Health PackagingAvKAREGolden State Medical Supply
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Keep bottles tightly closed (protect from moisture).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09AA01 Captopril
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 February 1996
- Identifiers
- RxCUI 308962, 308963, 308964 +1DailyMed set ID 1fbc9b28-ff10-4b17-a359-e12b4330747e, 3b789f16-b291-4012-be39-af3beec3ff9a, 2d3779b0-83d9-4b6f-a043-f7768cd7fce6 +8NDC 27241-160, 11788-135, 43547-363 +9Application ANDA212809, ANDA214442, ANDA074477 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 27241-160-01 | Ajanta PharmaIndia | 13 December 2019 |
| 1000 tablet in 1 bottle | 27241-160-10 | Ajanta PharmaIndia | 13 December 2019 |
| 100 tablet in 1 bottle | 31722-141-01 | Camber PharmaceuticalsIndia | 8 July 2021 |
| 1000 tablet in 1 bottle | 31722-141-10 | Camber PharmaceuticalsIndia | 8 July 2021 |
| 100 tablet in 1 bottle | 58657-735-01 | Method Pharmaceuticals | 15 June 2024 |
| 1000 tablet in 1 bottle | 58657-735-10 | Method Pharmaceuticals | 15 June 2024 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 58657-935-01 | Method Pharmaceuticals | 1 December 2025 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 58657-935-03 | Method Pharmaceuticals | 1 December 2025 |
| 100 tablet in 1 bottle | 11788-135-01 | AiPing Pharmaceutical | 1 April 2026 |
| 100 tablet in 1 bottle | 69292-522-01 | Amici Pharma | 20 August 2019 |
| 1000 tablet in 1 bottle | 69292-522-10 | Amici Pharma | 20 August 2019 |
| 100 tablet in 1 bottle | 0143-1171-01 | Hikma Pharmaceuticals | 13 February 1996 |
| 1000 tablet in 1 bottle | 0143-1171-10 | Hikma Pharmaceuticals | 13 February 1996 |
| 100 tablet in 1 bottle | 43547-363-10 | Solco Healthcare | 1 July 2016 |
| 1000 tablet in 1 bottle | 43547-363-11 | Solco Healthcare | 1 July 2016 |
| 30 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 60687-304-21 | American Health Packaging | 12 December 2017 |
| 100 tablet in 1 bottle | 73190-026-01 | AvKARE | 22 April 2025 |
| 100 tablet in 1 bottle | 51407-600-01 | Golden State Medical Supply | 13 September 2021 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-7105-61 | Major Pharmaceuticals | 13 December 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 April 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Captopril
Clinical summary
Captopril is an angiotensin converting enzyme inhibitor indicated for the treatment of hypertension, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Captopril for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CaptoprilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- captopril prescribing information (Amici Pharma) · U.S. National Library of Medicine, DailyMed
Need Captopril 12.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.